Story
Barclays Upgrades AkzoNobel and Arkema Amid Cautious Outlook for European Chemicals

Barclays has adopted a more selective stance on the European chemicals sector, upgrading AkzoNobel and Arkema while flagging potential headwinds for the second half of 2026. The bank's analysts now favor downstream specialty and defensive chemical companies, citing an uneven demand recovery and emerging macroeconomic risks.
A More Cautious Sector Stance
In a research note, analysts led by Katie Richards acknowledged that the second quarter delivered a "clear earnings recovery" for European chemical firms, with pricing turning positive year-over-year for the first time in three years. However, they cautioned that underlying demand trends remained mixed across different end-markets.
Barclays outlined several factors for its more cautious outlook, including:
- Fading pricing support related to disruptions in the Middle East.
- Re-emerging logistical risks tied to the Rhine river.
- Softening leading economic indicators.
- The sector trading near 18-month highs.
Given this backdrop, the bank stated a preference for "downstream specialty chemicals and defensive names such as Air Liquide," while maintaining an overall Negative stance on the European Chemicals & Ingredients sector.
Rating Upgrades
AdReflecting this strategic shift, Barclays upgraded AkzoNobel to Overweight from Equal Weight, raising its price target to €71 from €58. The analysts cited reduced uncertainty following the August 5 approval of the Axalta merger, an unrealized €600 million synergy target, a planned €2.5 billion special dividend, and improving fundamentals in its Automotive Refinish business.
Arkema was also upgraded to Equal Weight from Underweight, with its price target lifted to €56 from €51. The bank pointed to the company's improving capital allocation discipline and signs that construction markets, which represent about 40% of its end-market exposure, may have bottomed out.
Underweight Ratings Reiterated
Conversely, Barclays reiterated its Underweight ratings on several other major players. The bank noted that Lanxess and Solvay "carry some of the most demanding H2 recovery assumptions in the sector."
An Underweight rating was also maintained for BASF, with analysts highlighting less supportive petrochemical pricing and the company's exposure to cyclical and Rhine-related risks, despite what they described as relatively undemanding market expectations.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.